Chehelcheraghi Farzaneh, Bayat Mohammad, Chien Sufan
Anatomical Sciences Department, School of Medicine, Lorestan University Medical of Sciences, Khoramabad, IR Iran.
Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
J Invest Surg. 2020 Feb;33(2):123-133. doi: 10.1080/08941939.2018.1479006. Epub 2018 Jun 5.
: We investigated the effect of bone marrow mesenchymal stem cells (BMMSCs) and chicken embryo extract (CEE), alone and in combination, on tissue viability of skin flaps, and mast cells (MCs), in an experimental random skin flap (RSF) rat model. : A 30 mm × 80 mm RSF was made on the dorsum of each of the forty rats, which were then divided into four groups. One group did not receive any treatment and served as the control, the second group received BMMSCs, the third group received CEE + BMMSCs, and the fourth group received CEE. For BMMSC treatment, 6 × 10 BMMSCs were injected into twelve separate injection sites of each flap. Seven days after RSF surgery, the remaining viable part of each flap was measured and examined to determine the number of blood vessels, MCs, and degranulated MCs. : The CEE, CEE + BMMSC, and BMMSC groups displayed significantly higher levels of flap viability (ANOVA test: = 0.000; LSD test for all groups: = 0.000), and a greater number of vessels (ANOVA test: = 0.000; LSD test: = 0.000, 0.002, and 0.012, respectively), compared with the control group. The flap viability was poorer in the BMMSC group than in the CEE and CEE + BMMSC groups. The BMMSC group also had a greater number of degranulated and total MCs, compared with the CEE and CEE + BMMSC groups. : We observed biostimulatory effects of BMMSCs, CEE, and CEE + BMMSCs on flap viability and vessel numbers, compared to the control group. MCs produced in response to BMMSC treatment have an inhibitory effect on the RSFs survival in an ischemic tissue model.
我们在实验性随机皮瓣(RSF)大鼠模型中,研究了骨髓间充质干细胞(BMMSCs)和鸡胚提取物(CEE)单独及联合应用对皮瓣组织活力和肥大细胞(MCs)的影响。在40只大鼠的背部制作30mm×80mm的RSF,然后将其分为四组。一组不接受任何治疗作为对照组,第二组接受BMMSCs,第三组接受CEE+BMMSCs,第四组接受CEE。对于BMMSC治疗,将6×10的BMMSCs注入每个皮瓣的12个单独注射部位。RSF手术后7天,测量并检查每个皮瓣剩余的存活部分,以确定血管数量、MCs和脱颗粒MCs的数量。与对照组相比,CEE组、CEE+BMMSC组和BMMSC组的皮瓣活力水平显著更高(方差分析:F=0.000;所有组的LSD检验:P=0.000),血管数量更多(方差分析:F=0.000;LSD检验:P分别为0.000、0.002和0.012)。BMMSC组的皮瓣活力比CEE组和CEE+BMMSC组差。与CEE组和CEE+BMMSC组相比,BMMSC组的脱颗粒MCs和总MCs数量也更多。与对照组相比,我们观察到BMMSCs、CEE和CEE+BMMSCs对皮瓣活力和血管数量具有生物刺激作用。在缺血组织模型中,BMMSC治疗产生的MCs对RSF的存活具有抑制作用。